Solvonis Therapeutics plc (LON: SVNS)
London
· Delayed Price · Currency is GBP · Price in GBX 0.191
-0.019 (-9.05%)
Jan 22, 2025, 9:24 AM BST
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 4.36 million as of January 23, 2025. Its market cap has increased by 544.70% in one year.
Market Cap
4.36M
Enterprise Value
4.60M
Revenue
347.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 4.36M, a decrease of -81.06%. That is a compound annual growth rate of -42.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 4.36M | -7.32% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| Shell | 167.06B |
| HSBC Holdings | 145.32B |
| Unilever | 114.25B |
| Rio Tinto Group | 85.64B |
| RELX PLC | 74.08B |
| BP p.l.c. | 67.32B |
| British American Tobacco p.l.c. | 65.03B |